NDC 62935-453 – Eligard
· Kit · Subcutaneous
Product NDC62935-453
Product details
- Brand name
- Eligard
- Generic name
- Leuprolide Acetate
- Labeler
- TOLMAR Inc.
- Dosage form
- Kit
- Route
- Subcutaneous
- Marketing category
- NDA · NDA021731
- Marketed since
- January 7, 2005
- Listing expires
- December 31, 2026
Active ingredients
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62935-453-45 | 1 KIT in 1 CARTON (62935-453-45) * .375 mL in 1 SYRINGE (62935-454-44) * .375 mL in 1 SYRINGE (62935-455-45) | Jan 7, 2005 |
Recalls mentioning this NDC
- D-1178-2023 Oct 4, 2023 · Class III
Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
Other Eligard products
- 62935-223 · Kit · TOLMAR Inc.
- 62935-303 · Kit · TOLMAR Inc.
- 62935-753 · Kit · TOLMAR Inc.
- 62935-227 Leuprolide Acetate 22.5 mg/.375mL · Injection, Suspension, Extended Release · TOLMAR Inc.
- 62935-306 Leuprolide Acetate 30 mg/.5mL · Injection, Suspension, Extended Release · TOLMAR Inc.
- 62935-461 Leuprolide Acetate 45 mg/.375mL · Injection, Suspension, Extended Release · TOLMAR Inc.
- 62935-756 Leuprolide Acetate 7.5 mg/.25mL · Injection, Suspension, Extended Release · TOLMAR Inc.